Moxetumomab pasudotox and Tobramycin (Oral Inhalation)
Determining the interaction of Moxetumomab pasudotox and Tobramycin (Oral Inhalation) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
Generic Name: tobramycin
Brand name: Bethkis, Kitabis Pak, Tobi, TOBI Podhaler
Synonyms: Tobramycin (inhalation)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-Tobramycin (Systemic)
- Moxetumomab pasudotox-Tobramycin and Dexamethasone
- Moxetumomab pasudotox-Tobramycin and Dexamethasone Eye Drops
- Moxetumomab pasudotox-Tobramycin and Dexamethasone Eye Ointment
- Moxetumomab pasudotox-Tobramycin and dexamethasone Ophthalmic
- Moxetumomab pasudotox-Tobramycin in Sodium Chloride Injection
- Tobramycin (Oral Inhalation)-Moxetumomab Pasudotox-tdfk
- Tobramycin (Oral Inhalation)-Moxetumomab pasudotox-tdfk Intravenous
- Tobramycin (Oral Inhalation)-Moxifloxacin
- Tobramycin (Oral Inhalation)-Moxifloxacin (Systemic)
- Tobramycin (Oral Inhalation)-Moxifloxacin Hydrochloride
- Tobramycin (Oral Inhalation)-Moxifloxacin Injection